Research Paper Volume 15, Issue 7 pp 2734—2771

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma


Figure 11. The relationship between TSEN54 expression and immune infiltration in hepatocellular carcinoma. (A) The correlation between the immune cell infiltration level and the expression of TSEN54. (B) The connection between the CNV of TSEN54 and the immune cell infiltration level. (C) The relation between the TP53 mutation status and the immune cell infiltration level.